- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| BONE BIOLOGICS Aktie jetzt für 0€ handeln | |||||
| 09.07. | Bone Biologics Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 08.07. | Bone Biologics enters into definitive agreement for $3.0M private placement | 1 | Seeking Alpha | ||
| 08.07. | BONE BIOLOGICS CORPORATION: Bone Biologics Announces up to $9.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules | 121 | GlobeNewswire (Europe) | BURLINGTON, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation (Nasdaq: BBLG, BBLGW) ("Bone Biologics," or the "Company"), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 19.05. | Bone Biologics extends rhNELL-1 protein shelf life to 29 months | 1 | Investing.com | ||
| 19.05. | Bone Biologics verlängert Haltbarkeit von Protein rhNELL-1 auf 29 Monate | 1 | Investing.com Deutsch | ||
| 14.05. | Bone Biologics Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.03. | Bone Biologics kündigt 'At-the-Market'-Angebot über 1,06 Millionen US-Dollar an der NASDAQ an | 1 | Investing.com Deutsch | ||
| 13.03. | Bone Biologics Corp - 8-K, Current Report | 3 | SEC Filings | ||
| 02.03. | Bone Biologics Corp - 10-K, Annual Report | 3 | SEC Filings | ||
| 08.01. | BONE BIOLOGICS CORPORATION: Bone Biologics Highlights 2025 Key Operational, Scientific, and Corporate Milestones and Provides 2026 Outlook | 426 | GlobeNewswire (Europe) | BURLINGTON, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen | |
| 23.12.25 | BONE BIOLOGICS CORPORATION: Bone Biologics Improves Extension of rhNELL-1 Product Shelf Life to 24 Months | 350 | GlobeNewswire (Europe) | BURLINGTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Bone Biologics Corporation ("Bone Biologics" or the "Company") (NASDAQ: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets... ► Artikel lesen |
12 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ATOSSA THERAPEUTICS | 2,220 | +0,91 % | Atossa Therapeutics Inc: Atossa Therapeutics Announces Closing of Registered Direct Offering of up to $16.5 Million in Gross Proceeds | $4.5 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon exercise in full of warrants
SEATTLE, June 12, 2026 /PRNewswire/... ► Artikel lesen | |
| BUTTERFLY NETWORK | 6,012 | +2,51 % | Michael Burry sagt nur: wow: Butterfly +56 %: Die kleine Aktie hinter Midjourneys 60-Sekunden-Körperscanner | © Foto: Jaque Silva - NurPhotoMidjourney plant einen 60-Sekunden-Körperscanner per Ultraschall und KI. Butterfly liefert die Technik für den Prototyp. Anleger haben die Aktie am Donnerstag brutal hochgekauft... ► Artikel lesen | |
| BEYOND AIR | 5,910 | -1,17 % | XFRA 48L: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBEYOND AIR INC.... ► Artikel lesen | |
| ACCENDRA HEALTH | 2,620 | -4,38 % | ACCENDRA HEALTH INC/VA/ - 8-K, Current Report | ||
| AXOGEN | 34,560 | -0,12 % | NZS Capital Added Axogen (AXGN) as an Optionality Position | ||
| AETHLON MEDICAL | 0,610 | +1,38 % | Aethlon Medical, Inc.: Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier | Second cohort findings consistent with previously reported observations; independent statistical analysis planned following completion of all three patient cohorts
... ► Artikel lesen | |
| AVANOS MEDICAL | 21,800 | -0,91 % | Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger | ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced... ► Artikel lesen | |
| ANGIODYNAMICS | 12,400 | +3,33 % | H.C. Wainwright raises AngioDynamics stock price target on growth | ||
| APYX MEDICAL | 3,780 | +5,59 % | Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System | CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the "Company" or "Apyx Medical"), the leader in surgical aesthetics products marketed and sold as Renuvion... ► Artikel lesen | |
| ANTERIS TECHNOLOGIES GLOBAL | 8,490 | +3,28 % | ANTERIS TECHNOLOGIES GLOBAL CORP.: Application for quotation of securities - AVR | ||
| ADAPTHEALTH | 11,200 | +2,00 % | Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln Total | WASHINGTON (dpa-AFX) - Healthcare services company Cardinal Health, Inc. (CAH) announced late Monday its agreement to acquire the Diabetes Health business of AdaptHealth Corp. (AHCO), as well... ► Artikel lesen | |
| ENVUE MEDICAL | 0,359 | -3,72 % | ENvue Medical, Inc.: ENvue Medical Appoints Chairman of the Board and New Directors, Bringing Clinical, AI Governance and Capital Markets Expertise to Navigation Platform | Zeev Rotstein, M.D. Named Chairman Following Four Decades in Health System Leadership, Including 12 Years as Director General of Sheba Medical Center Zvi Joseph and Lior Buchman Join Board, Bringing... ► Artikel lesen | |
| GLUCOTRACK | 0,372 | -8,97 % | Glucotrack Gains Slightly on Bridge Financing Deal | ||
| BLUEJAY DIAGNOSTICS | 1,140 | -5,79 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 4,170 | -1,42 % | Autonomix Medical, Inc.: Autonomix Medical Granted U.S. Patent for Overactive Bladder Diagnosis and Treatment Platform | Newly Issued Patent Expands Company's Neural Sensing Technology Platform into Large Urology Market Affecting Approximately 37 Million Americans THE WOODLANDS, TX, July 15, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen |
BONE BIOLOGICS CORP gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 1,120 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BONE BIOLOGICS CORP finden Sie auf Wallstreet Online.